🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

30,79 USD

Máx. histórico

61,25

1784 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-49,73%

Rango 52 semanas

23,62 – 31,06

Variación hoy

+2,63%

Cierre anterior

30,00

Rango de hoy

30,04 – 30,90

Volumen hoy

48.251.619

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,61 (puede no estar actualizado)
Dividend yield
5,73% (puede no estar actualizado)
Precio objetivo analistas
29,45 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 2 horas
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,7200 USD · Yield: 5,59%
Fecha de pago Importe por participación
03/11/2022 0,4000 USD
28/07/2022 0,4000 USD
12/05/2022 0,4000 USD
27/01/2022 0,4000 USD
04/11/2021 0,3900 USD
29/07/2021 0,3900 USD
06/05/2021 0,3900 USD
28/01/2021 0,3900 USD
05/11/2020 0,3605 USD
30/07/2020 0,3605 USD
07/05/2020 0,3605 USD
30/01/2020 0,3605 USD
07/11/2019 0,3416 USD
01/08/2019 0,3416 USD
09/05/2019 0,3416 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/09/2021 44,56 45,37 44,47 44,77 +0,13% 2,02% 28.674.600
14/09/2021 44,67 45,26 44,55 44,71 +0,29% 1,59% 24.100.200
13/09/2021 45,74 45,83 44,20 44,58 -2,22% 3,56% 37.086.200
10/09/2021 46,27 46,35 45,51 45,59 -0,96% 1,82% 20.801.500
09/09/2021 46,47 46,72 45,85 46,03 -1,03% 1,87% 21.695.300
08/09/2021 46,51 46,79 46,25 46,51 -0,51% 1,16% 15.839.600
07/09/2021 46,99 47,50 46,54 46,75 -0,19% 2,04% 26.236.900
03/09/2021 46,90 47,03 46,34 46,84 +0,00% 1,47% 20.817.200
02/09/2021 46,48 46,87 46,13 46,84 +1,74% 1,59% 26.106.300
01/09/2021 46,19 46,26 45,42 46,04 -0,07% 1,82% 32.900.100
31/08/2021 46,72 47,14 45,93 46,07 -1,48% 2,59% 34.547.800
30/08/2021 46,20 47,16 46,16 46,76 +0,34% 2,16% 25.774.400
27/08/2021 47,37 47,50 46,53 46,60 -1,65% 2,05% 32.924.500
26/08/2021 47,70 48,16 47,30 47,38 -0,27% 1,80% 29.029.300
25/08/2021 48,04 48,28 46,93 47,51 -1,80% 2,81% 51.036.800
24/08/2021 49,74 50,05 48,24 48,38 -3,10% 3,64% 52.624.100
23/08/2021 50,29 51,36 49,60 49,93 +2,48% 3,50% 88.652.400
20/08/2021 48,98 49,73 48,66 48,72 -0,16% 2,18% 35.157.500
19/08/2021 48,50 49,96 48,26 48,80 -1,03% 3,51% 57.741.600
18/08/2021 50,23 51,86 49,17 49,31 -2,20% 5,36% 88.598.000
17/08/2021 48,78 50,49 48,71 50,42 +3,09% 3,65% 68.817.000
16/08/2021 48,23 48,97 47,51 48,91 +0,89% 3,03% 38.045.800
13/08/2021 47,41 48,50 47,32 48,48 +2,62% 2,49% 35.379.200
12/08/2021 46,50 47,40 46,34 47,24 +2,01% 2,28% 29.676.400
11/08/2021 47,78 48,08 46,26 46,31 -3,90% 3,81% 50.878.200
10/08/2021 46,20 48,57 45,89 48,19 +4,81% 5,80% 81.189.400
09/08/2021 45,11 46,03 45,11 45,98 +2,02% 2,04% 32.374.300
06/08/2021 45,09 45,31 44,63 45,07 +0,02% 1,51% 20.413.000
05/08/2021 45,00 45,14 44,70 45,06 -0,29% 0,98% 23.505.400
04/08/2021 45,35 45,80 45,01 45,19 -1,07% 1,74% 43.391.200